Annual Short Term Debt
$502.66 M
+$492.28 M+4744.88%
31 December 2023
Summary:
BioMarin Pharmaceutical annual short term debt is currently $502.66 million, with the most recent change of +$492.28 million (+4744.88%) on 31 December 2023. During the last 3 years, it has risen by +$490.90 million (+4176.47%). BMRN annual short term debt is now at all-time high.BMRN Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$8.06 M
-$497.47 M-98.41%
30 September 2024
Summary:
BioMarin Pharmaceutical quarterly short term debt is currently $8.06 million, with the most recent change of -$497.47 million (-98.41%) on 30 September 2024. Over the past year, it has dropped by -$494.66 million (-98.40%). BMRN quarterly short term debt is now -98.41% below its all-time high of $505.53 million, reached on 30 June 2024.BMRN Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4744.9% | -98.4% |
| 3 y3 years | +4176.5% | -16.6% |
| 5 y5 years | +100.0% | -21.2% |
BMRN Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +4744.9% | -98.4% | at low |
| 5 y | 5 years | at high | -98.4% | at low | |
| alltime | all time | at high | -98.4% |
BioMarin Pharmaceutical Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.06 M(-98.4%) |
| June 2024 | - | $505.53 M(+0.5%) |
| Mar 2024 | - | $502.93 M(+0.1%) |
| Dec 2023 | $502.66 M(+4744.9%) | $502.66 M(-0.0%) |
| Sept 2023 | - | $502.72 M(+5961.3%) |
| June 2023 | - | $8.29 M(-10.3%) |
| Mar 2023 | - | $9.25 M(-10.8%) |
| Dec 2022 | $10.38 M(-0.9%) | $10.38 M(+12.5%) |
| Sept 2022 | - | $9.23 M(-13.1%) |
| June 2022 | - | $10.61 M(-2.0%) |
| Mar 2022 | - | $10.83 M(+3.5%) |
| Dec 2021 | $10.46 M(-11.0%) | $10.46 M(+8.3%) |
| Sept 2021 | - | $9.66 M(-12.4%) |
| June 2021 | - | $11.02 M(-1.8%) |
| Mar 2021 | - | $11.23 M(-4.5%) |
| Dec 2020 | $11.75 M(-96.8%) | $11.75 M(-96.9%) |
| Sept 2020 | - | $385.22 M(+1.0%) |
| June 2020 | - | $381.49 M(+1.4%) |
| Mar 2020 | - | $376.37 M(+1.0%) |
| Dec 2019 | $372.58 M(>+9900.0%) | $372.58 M(+3543.8%) |
| Sept 2019 | - | $10.22 M(+0.6%) |
| June 2019 | - | $10.16 M(+10.4%) |
| Mar 2019 | - | $9.21 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2018 | - | $374.23 M(+1.2%) |
| June 2018 | - | $369.75 M(+1.2%) |
| Mar 2018 | - | $365.33 M(+1.2%) |
| Dec 2017 | $360.95 M(+1505.8%) | $360.95 M(+1504.6%) |
| Mar 2017 | - | $22.50 M(+0.1%) |
| Dec 2016 | $22.48 M(-3.8%) | $22.48 M(+0.1%) |
| Sept 2016 | - | $22.46 M(-8.0%) |
| June 2016 | - | $24.42 M(+4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $23.36 M(-67.0%) | $23.36 M(-0.3%) |
| Sept 2012 | - | $23.44 M(0.0%) |
| June 2012 | - | $23.44 M(-0.1%) |
| Mar 2012 | - | $23.45 M(-66.6%) |
| Mar 2009 | - | $70.32 M(-0.6%) |
| Dec 2008 | $70.74 M(+942.3%) | $70.74 M(+1116.3%) |
| June 2008 | - | $5.82 M(-4.1%) |
| Mar 2008 | - | $6.07 M(-7.4%) |
| Sept 2007 | - | $6.55 M(-3.5%) |
| June 2007 | - | $6.79 M(-0.0%) |
| Mar 2007 | - | $6.79 M(-0.0%) |
| Dec 2006 | $6.79 M(-40.1%) | $6.79 M(0.0%) |
| Sept 2006 | - | $6.79 M(+1.2%) |
| June 2006 | - | $6.71 M(-75.2%) |
| Mar 2006 | - | $27.05 M(+138.6%) |
| Dec 2005 | $11.34 M(-73.5%) | $11.34 M(-3.1%) |
| Sept 2005 | - | $11.70 M(-3.7%) |
| June 2005 | - | $12.14 M(-51.5%) |
| Mar 2005 | - | $25.06 M(-41.5%) |
| Dec 2004 | $42.80 M(+2590.4%) | $42.80 M(-12.2%) |
| Sept 2004 | - | $48.75 M(-16.3%) |
| June 2004 | - | $58.23 M(+3289.3%) |
| Mar 2002 | - | $1.72 M(+8.0%) |
| Dec 2001 | $1.59 M(+5792.6%) | $1.59 M(+1574.7%) |
| Sept 2001 | - | $95.00 K(-3.1%) |
| June 2001 | - | $98.00 K(+237.9%) |
| Mar 2001 | - | $29.00 K(+7.4%) |
| Dec 2000 | $27.00 K(+3.8%) | $27.00 K(-3.6%) |
| Sept 2000 | - | $28.00 K(-3.4%) |
| June 2000 | - | $29.00 K(+11.5%) |
| Mar 2000 | - | $26.00 K(0.0%) |
| Dec 1999 | $26.00 K | $26.00 K |
FAQ
- What is BioMarin Pharmaceutical annual short term debt?
- What is the all time high annual short term debt for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual short term debt year-on-year change?
- What is BioMarin Pharmaceutical quarterly short term debt?
- What is the all time high quarterly short term debt for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly short term debt year-on-year change?
What is BioMarin Pharmaceutical annual short term debt?
The current annual short term debt of BMRN is $502.66 M
What is the all time high annual short term debt for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual short term debt is $502.66 M
What is BioMarin Pharmaceutical annual short term debt year-on-year change?
Over the past year, BMRN annual short term debt has changed by +$492.28 M (+4744.88%)
What is BioMarin Pharmaceutical quarterly short term debt?
The current quarterly short term debt of BMRN is $8.06 M
What is the all time high quarterly short term debt for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly short term debt is $505.53 M
What is BioMarin Pharmaceutical quarterly short term debt year-on-year change?
Over the past year, BMRN quarterly short term debt has changed by -$494.66 M (-98.40%)